The Localisation of Radiolabeled Murine Monoclonal Antibody 81C6 and its Fab Fragment in Human Glioma Xenografts in Athymic Mice

References

• Bourdon M A, Wikstrand C J, Furthmayr H, Matthews T J, Bigner D D. Human glioma-mesenchymal extracellular matrix antigen defined by monoclonal antibody. Cancer Res 1983; 43: 2796–805
   PubMed Web of Science ®Google Scholar
• Bullard D E, Adams C J, Coleman R E, Bigner D D. In vivo imaging of intracranial human glioma xenografts comparing specific with nonspecific radiolabeled monoclonal antibodies. J Neurosurg 1986; 64: 257–62
   PubMed Web of Science ®Google Scholar
• Erickson H P, Taylor H C. Hexabrachion protein in embryonic chicken tissues and human tumors. J Cell Biol 1987; 105: 1387–94
   PubMed Web of Science ®Google Scholar
• Bourdon M A, Coleman R E, Blasberg R G, Groothuis D R, Bigner D D. Monoclonal antibody localisation in subcutaneous and intracranial human xenografts: paired label and imaging analysis. Anticancer Res 1984; 4: 133–40
   PubMed Web of Science ®Google Scholar
• Lee Y S, Bullard D E, Zalutsky M R, Coleman R E, Wikstrand C J, Friedman H S, Colapinto E V, Bigner D D. Therapeutic efficacy of anti-glioma mesenchymal extracellular matrix 131I-radiolabeled murine monoclonal antibody. Cancer Res 1988; 48: 559–66
   PubMed Web of Science ®Google Scholar
• Lee Y S, Bullard D E, Humphrey P A, Colapinto E V, Friedman H S, Zalutsky M R, Coleman R E, Bigner D D. Treatment of intracranial human glioma xenografts with 131I anti-tenascin monoclonal antibody (Mab) 81C6. Cancer Res, in press
   Google Scholar
• Mosely R, Zalutsky M R, Coakham H B, Coleman R E, Bigner D D. Distribution of 1–131 81C6 monoclonal antibody (Mab) administered via carotid artery in patients with glioma (G). Proceedings of the 34th Annual Meeting. J Nuc Med 1987; 28: 603–4
   Google Scholar
• Wahl R L, Parker C W, Philpott G W. Improved radio-imaging and tumor localization with monoclonal F(ab')2. J Nuc Med 1983; 24: 316–25
   PubMed Web of Science ®Google Scholar
• Colcher D, Zalutsky M, Kaplan W, Kufe D, Austin F, Schlom J. Radiolocalization of human mammary tumors in athymic mice by a monoclonal antibody. Cancer Res 1983; 43: 736–42
   PubMed Web of Science ®Google Scholar
• Buchegger F, Haskell C, Schreyer M, Scazziga B R, Randin S, Cavvel S, Mach J-P. Radiolabeled fragments of monoclonal antibodies against carcinoembryonic antigen for localization of human colon carcinoma grafted into nude mice. J Exp Med 1983; 158: 413–27
   PubMed Web of Science ®Google Scholar
• Larson S M, Carasquillo J A, Krohn K A, Brown J P, McGuffin R W, Ferens J M, Graham M M, Hill L D, Beaumier P L, Hellstrom K E, Hellstrom I. Localization of 131I-labeled p97-specific fragments in human melanoma as a basis for radiotherapy. J Clin Invest 1983; 72: 2101–14
   PubMed Web of Science ®Google Scholar
• Carasquillo J A, Krohn K A, Beaumier P, McGuffin R W, Brown J P, Hellstrom K E, Hellstrom I, Larson S M. Diagnosis of and therapy for solid tumors with radiolabeled antibodies and immune fragments. Can Treat Rep 1984; 68: 317–28
   PubMedGoogle Scholar
• Delaloye B, Bishof-Deleloye A, Buchegger F, von Fliedner V, Grob J-P, Volant J-C, Pettavel J, Mach J-P. Detection of colorectal carcinoma by emission-computerized tomography after injection of 123I-labelled Fab or F(ab')2 fragments from monoclonal anti-carcinoembryonic antigen antibodies. J Clin Invest 1986; 77: 301–11
   PubMed Web of Science ®Google Scholar
• Buchegger F, Mach J-P, Leonnard B S, Carrel S. Selective tumor localization of radiolabeled anti-human melanoma monoclona antibody fragment demonstrated in the nude mouse model. Cancer 1986; 58: 655–62
   PubMed Web of Science ®Google Scholar
• Ghose T, Blair A H, Martin R H, Norvell S T, Ramakrishman S, Belitsky P, Imai K, Ferrone S. Tumor imaging by antitumor antibody-linked radionuclides: experimental models and clinical applications. Tumor Imaging, S W Burchiel, B A Rhodes, B Friedman. Masson, New York 1982; 167–78
   Google Scholar
• Takahashi H, Herlyn D, Atkinson B, Powe J, Rodeck U, Alavi A, Bruce D A, Koprowski H. Radioimmuno-detection of human glioma xenografts by monoclonal antibody to epidermal growth factor receptor. Cancer Res 1987; 47: 3847–50
   PubMed Web of Science ®Google Scholar
• Schold S C, Bullard D E, Bigner S H, Jones T R, Bigner D D. Growth, morphology, and serial transplantation of anaplastic gliomas in athymic mice. J Neuro-oncol 1983; 1: 5–14
   PubMedGoogle Scholar
• Bullard D E, Schold S C, Bigner S H, Bigner D D. Growth and chemotherapeutic response in athymic mice of tumors arising from human glioma-derived cell lines. J Neuropath Exp Neurol 1981; 40: 410–27
   PubMed Web of Science ®Google Scholar
• Ey P L, Prowse S J, Jenkin C R. Isolation of pure IgGl, IgG2a, and IgG2b immunoglobulins from mouse serum using protein A-sepharose. Immunochem 1978; 15: 429–43
   PubMedGoogle Scholar
• Parham P. On the fragmentation of monoclonal IgG1, IgG2a, and IgG2b from Balb/c mice. J Immunol 1983; 131: 2895–902
   PubMed Web of Science ®Google Scholar
• Greenwood F C, Hunter W M, Glover J S. The preparation of 131 -I labeled human growth hormones of high specific radioactivity. Biochem J 1963; 89: 114–20
   PubMed Web of Science ®Google Scholar
• Laemmli U K. Cleavage of structural proteins during the assembly of the head of the bacteriophage T4. Nature (London) 1970; 270: 680–8
   Google Scholar
• Trucco M, de Petris S. Determination of equilibrium binding parameters of monoclonal antibodies specific for cell surface antigens. Immunological Methods, I Lefkovits, B Pernis. Academic Press, New York 1981; Volume II: 1–26
   Google Scholar
• Moshakis V, McLlhinney R AJ, Raghaven D, Neville A M. Localization of human tumour xenografts after I.V. administration of radiolabeled monoclonal antibodies. Br J Cancer 1981; 44: 91–9
   PubMed Web of Science ®Google Scholar
• Badger C C, Krohn K A, Peterson A V, Shulman H, Bernstein I D. Experimental radiotherapy of murine lymphoma with 131-I-labelled Anti-Thy 1.1 monoclonal antibody. Cancer Res 1985; 45: 1536–44
   PubMed Web of Science ®Google Scholar
• Dillman L T. Radionuclide decay schemes and nuclear parameters for use in radiation-dose estimation. The Society of Nuclear Medicine 1969, MIRD Pamphlet No. 4
   Google Scholar
• Wikstrand C J, McLendon R E, Carrel S, Kemshead J T, Mach J P, Coakham H B, De Tribolet N, Bullard D E, Zalutsky M R, Bigner D D. Comparative localization of glioma reactive monoclonal antibodies in an athymic mouse human glioma xenograft model. J Neuroim-munol 1987; 15: 37–56
   PubMed Web of Science ®Google Scholar
• Bourdon M A, Coleman R E, Bigner D D. The potential of monoclonal antibodies as carriers of radiation and drugs for immunodetection and therapy of brain tumors. Prog Exp Tumor Res 1984; 28: 79–100
   PubMed Web of Science ®Google Scholar
• Kennel S J, Foote L J, Lankford P K, Johnson M, Mitchell T, Braslawsky G R. Direct binding of radio-iodinated monoclonal antibody to tumor cells: significance of antibody purity and affinity for drug targeting and tumor imaging. Hybridoma 1983; 2: 297–310
   PubMedGoogle Scholar
• Burchiel S W, Khaw B A, Rhodes B A, Smith T W, Haber E. Immunopharmacokinetics of radiolabeled antibodies and their fragments. Radioimmunoimaging and Radioim-munotherapy, S W Burchiel, B A Rhodes. Elsevier, New York 1983; 125–39
   Google Scholar
• Covell D G, Barbet J, Holton O D, Black C DV, Parker R J, Weinstein J N. Pharmacokinetics of monoclonal immunoglobulin Gl, F(ab')2, and Fab' in mice. Cancer Res 1986; 46: 3969–78
   PubMed Web of Science ®Google Scholar
• Blasberg R G, Nakagawa H, Bourdon M A, Groothuis D, Patlak C S, Bigner D D. Regional localization of a glioma associated antigen defined by monoclonal antibody 81C6: kinetics and implications for diagnosis and therapy. Cancer Res 1987; 47: 4432–43
   PubMed Web of Science ®Google Scholar
• Jones D H, Lashford L S, Dicks-Mireaux C, Kemshead J T. Comparison of pharmacokinetics of radiolabeled monoclonal antibody UJ13A in patients and animal models. NCI Monographs 1987; 3: 125–30
   Google Scholar